Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.
Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient.
The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
More recognized is the relationship between gastric mucosa-associated lymphoid tissue (MALT) lymphomas, which are similar to primary cutaneous B-cell lymphomas
in the skin, and Helicobacter pylori infections.
Programmed death-1 expression in cutaneous B-cell lymphoma
In this clinical report, we describe the successful treatment of nonepitheliotropic cutaneous B-cell lymphoma
in an umbrella cockatoo.
reported finding hepatitis C virus RNA sequences by reverse-transcriptase PCR in 7 of 23 tumor biopsies of various clinicopathologic subforms of cutaneous B-cell lymphoma.
burgdorferi might be a causative agent in some cutaneous B-cell lymphomas first emerged in the late 1990s with a European report that 9 of 50 consecutively studied archival tissue specimens of confirmed cutaneous B-cell lymphomas contained specific DNA sequences belonging to B.
Primary cutaneous large B-celllymphomas of the legs: adistincttype of cutaneous B-cell lymphoma with an intermediate prognosis; Dutch Cutaneous Lymphoma Working Group.
Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Cutaneous B-cell lymphomas
of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
T-cell lymphomas (6%), 2 lymphomatoid papulosis (6%), 1 Sezary syndrome (3%), and 1 subcutaneous panniculitislike T-cell lymphoma (3%); 8 cases (26%) were primary cutaneous B-cell lymphomas
, including 3 primary cutaneous marginal zone B-cell lymphomas (10%), 3 primary cutaneous follicle center lymphomas (10%), and 2 primary cutaneous diffuse large B-cell lymphomas (6%), leg type.